Use of sertraline hydrochloride in the treatment of refractory neurocardiogenic syncope in children and adolescents.

[1]  D. Kosinski,et al.  Head-upright tilt table testing in children with unexplained syncope. , 1993, Pediatrics.

[2]  R. Campbell,et al.  Efficacy of alpha-adrenergic agonist therapy for prevention of pediatric neurocardiogenic syncope. , 1993, Journal of the American College of Cardiology.

[3]  S. Hjorth,et al.  In vivo microdialysis evidence for central serotonin1A and serotonin1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. , 1993, The Journal of pharmacology and experimental therapeutics.

[4]  B. Grubb,et al.  Usefulness of Fluoxetine Hydrochloride for Prevention of Resistant Upright Tilt Induced Syncope , 1993, Pacing and clinical electrophysiology : PACE.

[5]  S. Hjorth.  (-)-Penbutolol as a blocker of central 5-HT1A receptor-mediated responses. , 1992, European journal of pharmacology.

[6]  B. Grubb,et al.  Reproducibility of Head Upright Tilt Table Test Results in Patients with Syncope , 1992, Pacing and clinical electrophysiology : PACE.

[7]  R. Sheldon,et al.  Reproducibility of isoproterenol tilt-table tests in patients with syncope. , 1992, The American journal of cardiology.

[8]  B. Grubb,et al.  The Use of Head‐Upright Tilt Table Testing in the Evaluation and Management of Syncope in Children and Adolescents , 1992, Pacing and clinical electrophysiology : PACE.

[9]  D. Benditt,et al.  Reproducibility of head-up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. , 1992, The American journal of cardiology.

[10]  W. vonScheidt.  Diagnostic evaluation of syncope , 1992 .

[11]  B. Strasberg,et al.  Head-up tilt for the evaluation of syncope of unknown origin in children. , 1991, The Journal of pediatrics.

[12]  O. Thilenius,et al.  Tilt test for diagnosis of unexplained syncope in pediatric patients. , 1991, Pediatrics.

[13]  J Ludbrook,et al.  Hemodynamic and neurohumoral responses to acute hypovolemia in conscious mammals. , 1991, The American journal of physiology.

[14]  B. Koe.  Preclinical pharmacology of sertraline: a potent and specific inhibitor of serotonin reuptake. , 1990, The Journal of clinical psychiatry.

[15]  K. Rickels,et al.  Clinical overview of serotonin reuptake inhibitors. , 1990, The Journal of clinical psychiatry.

[16]  J. Strasburger,et al.  Heart rate and blood pressure response to upright tilt in young patients with unexplained syncope. , 1990, Journal of the American College of Cardiology.

[17]  C. Gornick,et al.  Usefulness of disopyramide for prevention of upright tilt-induced hypotension-bradycardia. , 1990, The American journal of cardiology.

[18]  C. Gornick,et al.  Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. , 1989, The New England journal of medicine.

[19]  A. Mark,et al.  Serotonergic mechanisms mediate renal sympathoinhibition during severe hemorrhage in rats. , 1988, The American journal of physiology.

[20]  J. Heym,et al.  Pharmacology of sertraline: a review. , 1988, The Journal of clinical psychiatry.

[21]  R. Kenny,et al.  HEAD-UP TILT: A USEFUL TEST FOR INVESTIGATING UNEXPLAINED SYNCOPE , 1986, The Lancet.

[22]  G. Feuerstein,et al.  The use of antiserotonergic agents for the treatment of acute hemorrhagic shock of cats. , 1985, European journal of pharmacology.

[23]  W. Kapoor,et al.  A prospective evaluation and follow-up of patients with syncope. , 1983, The New England journal of medicine.

[24]  W. Lovenberg,et al.  Review of the Role of the Central Serotonergic Neuronal System in Blood Pressure Regulation , 1980, Hypertension.

[25]  A. Boué,et al.  Better perinatal health. France. , 1979, Lancet.

[26]  F. Abboud,et al.  Neurocardiogenic syncope. , 1993, The New England journal of medicine.

[27]  D. Gold,et al.  Impairment of physical and psychosocial function in recurrent syncope. , 1991, Journal of clinical epidemiology.